Develops proteomic assays for researchers studying diseases.
Jun 2026Revenue $14.2M/yrExpenses $85.0M/yr
No trendCash runway ≈ 3.5 years from Jun 2026
Figures by year
When will Seer be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $14.2M and expenses $85.0M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $16.6M | $94.6M | −$78.0M |
| Dec 2024 | $14.2M | $114M | −$100M |
| Dec 2023 | $16.7M | $120M | −$103M |
| Dec 2022 | $15.5M | $113M | −$97.2M |
| Dec 2021 | $6.62M | $78.1M | −$71.5M |
| Dec 2020 | $656K | $34.3M | −$33.6M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.